When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Pfizer's twice-daily weight-loss pill discontinued due to ...

   www.aol.com/news/ozempic-without-injection...

   Weight loss with Ozempic or Wegovy requires an injection, but Pfizer is developing a similar drug in pill form. What to know about side effects, approval. Pfizer's twice-daily weight-loss pill ...

3. 6 Potential Long-Term Effects of Ozempic - AOL

   www.aol.com/6-potential-long-term-effects...

   Because the medication hasn’t been around long enough, more research is needed to understand any potential semaglutide long-term side effects beyond blood sugar control and weight loss. Ozempic ...

4. Is there an Ozempic pill? What to know about the latest ... - AOL

   www.aol.com/ozempic-pill-know-latest-weight...

   Stomach pain. Constipation. Clinical trial data for Ozempic show nausea is the most common side effect, followed by vomiting, diarrhea and abdominal pain. Azar said that ongoing research into Novo ...

5. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   The most common side effects of these drugs that led to withdrawals were mental disturbances, cardiac side effects, and drug abuse or drug dependence. Deaths were associated with seven products. [85] Ephedra was removed from the US market in 2004 over concerns that it raises blood pressure and could lead to strokes and death. [86]

6. List of withdrawn drugs - Wikipedia

   en.wikipedia.org/wiki/List_of_withdrawn_drugs

   Diversion, abuse, and a relatively high rate of overdose deaths in comparison to other drugs of its group. This drug continues to be available in most of the world including the US, but under strict controls. Terfenadine (Seldane, Triludan) 1997–1998 France, South Africa, Oman, others, US Prolonged QT interval; ventricular tachycardia [2] [3]

7. Novo Nordisk experimental obesity pill has mild-to-moderate ...

   www.aol.com/news/novo-nordisk-experimental...

   The maker of blockbuster drugs Wegovy and Ozempic said in March that a Phase I trial of the pill version of amycretin showed participants lost up to 13.1% of their weight after 12 weeks, prompting ...